Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Full Paper
  • Published:

Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata

Genes & Immunity volume 6, pages 285–289 (2005)Cite this article

Abstract

We have demonstrated that serum macrophage migration inhibitory factor (MIF) was significantly elevated in patients with extensive alopecia areata (AA). Recently, functional polymorphisms have been identified in the MIF promoter region. To address the functional and prognostic relevance of the −173G/C and −794[CATT]5–8 repeat polymorphisms in MIF genes in patients with extensive AA, 113 patients with extensive AA and 194 healthy controls were genotyped. We found that MIF−173*C was a risk factor for early onset (<20 years) of extensive AA (odds ratio for GC heterozygotes with −173G/C was 4.88 (95% CI, 2.04–11.8), P=0.00038; odds ratio for CC homozygotes with −173G/C was 10.42 (95% CI, 2.56–43.5), P=0.0011). We found no statistically significant differences in the genotype frequencies of the −794[CATT]5–8 repeat polymorphism and extensive AA. These results suggest that polymorphisms within the MIF−173*C allele confer an increased risk of susceptibility to the extensive forms of AA, especially with an early onset of disease. MIF is therefore suggested to be closely implicated in the pathogenesis of the more extensive forms of AA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Galbraith GM, Pandey JP . Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet 1995; 96: 433–436.

    Article  CAS  Google Scholar 

  2. Tazi-Ahnini R, Cox A, McDonagh AJ et al. Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction. Eur J Immunogenet 2002; 29: 25–30.

    Article  CAS  Google Scholar 

  3. Bloom BR, Bennett B . Mechanism of reaction in vivo associated with delayed-type hypersensitivity. Science 1966; 153: 80–82.

    Article  CAS  Google Scholar 

  4. Calandra T, Bernhagen J, Mitchell RA, Bucala R . The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179: 1895–1902.

    Article  CAS  Google Scholar 

  5. Shimizu T . Role of macrophage migration inhibitory factor (MIF) in the skin. J Dermatol Sci 2005; 37: 65–73.

    Article  CAS  Google Scholar 

  6. Donn R, Alourfi Z, De Benedetti F, et al, British Paediatric Rheumatology Study Group. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2402–2409.

    Article  CAS  Google Scholar 

  7. Baugh JA, Chitnis S, Donnelly SC et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002; 3: 170–176.

    Article  CAS  Google Scholar 

  8. Shimizu T, Nishihira J, Mizue Y, Abe R, Watanabe H, Shimizu H . Increased macrophage migration inhibitory factor (MIF) in sera of patients with extensive alopecia areata. J Invest Dermatol 2002; 118: 555–557.

    Article  CAS  Google Scholar 

  9. Olsen EA, Hordinsky MK, Price VH et al. Alopecia areata investigational assessment guidelines—Part II. J Am Acad Dermatol 2004; 51: 440–447.

    Article  Google Scholar 

  10. David JR . Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell–antigen interaction. Proc Natl Acad Sci USA 1966; 56: 72–77.

    Article  CAS  Google Scholar 

  11. Weiser WY, Temple PA, Witek-Giannotti JS, Remold HG, Clark SC, David JR . Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1989; 86: 7522–7526.

    Article  CAS  Google Scholar 

  12. Bernhagen J, Calandra T, Mitchell RA et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365: 756–759.

    Article  CAS  Google Scholar 

  13. Bucala R . MIF re-evaluated: pituitary hormone and glucocorticoid-induced regulator of cytokine production. FASEB J 1996; 7: 19–24.

    CAS  Google Scholar 

  14. McDonagh AJ, Tazi-Ahnini R . Epidemiology and genetics of alopecia areata. Review. Clin Exp Dermatol 2002; 27: 405–409.

    Article  CAS  Google Scholar 

  15. Tobin SJ . Morphological analysis of hair follicles in alopecia areata. Microsc Res Tech 1997; 38: 443–451.

    Article  CAS  Google Scholar 

  16. Harmon CS, Nevins TD . IL-1α inhibits human hair follicle growth and hair fiber production in whole-organ cultures. Lymphokines Cytokines Res 1993; 12: 197–203.

    CAS  Google Scholar 

  17. Philpott MP, Sanders DA, Bowen J, Kealey T . Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata. Br J Dermatol 1996; 135: 942–948.

    Article  CAS  Google Scholar 

  18. Galbraith GM, Palesch Y, Gore EA, Pandey JP . Contribution of interleukin 1beta and KM loci to alopecia areata. Hum Hered 1999; 49: 85–89.

    Article  CAS  Google Scholar 

  19. Tarlow JK, Clay FE, Cork MJ et al. Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994; 103: 387–390.

    Article  CAS  Google Scholar 

  20. Shimizu T, Abe R, Ohkawara A, Nishihira J . Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis. J Allergy Clin Immunol 1999; 104: 659–664.

    Article  CAS  Google Scholar 

  21. Foote A, Kipen Y, Santos L, Leech M, Morand EF . Macrophage migration inhibitory factor in systemic lupus erythematosus. J Rheumatol 2004; 31: 268–273.

    CAS  Google Scholar 

  22. Kleemann R, Hausser A, Geiger G et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000; 408: 211–216.

    Article  CAS  Google Scholar 

  23. Donnelly SC, Haslett C, Reid PT et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997; 3: 320–323.

    Article  CAS  Google Scholar 

  24. Barton A, Lamb R, Symmons D et al. Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun 2003; 4: 487–491.

    Article  CAS  Google Scholar 

  25. Donn RP, Shelley E, Oliver WE, Thomson W . A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 1782–1785.

    Article  CAS  Google Scholar 

  26. Donn R, Alourfi Z, Zeggini E, et al. British Paediatric Rheumatology Study Group. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 2004; 50: 1604–1610.

    Article  Google Scholar 

  27. Hizawa N, Yamaguchi E, Takahashi D, Nishihira J, Nishimura M . Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med 2004; 169: 1014–1018.

    Article  Google Scholar 

  28. Colombe BW, Lou CD, Price VH . The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J Invest Dermatol Symp Proc 1999; 4: 216–219.

    Article  CAS  Google Scholar 

  29. Hanifin JM, Rajika G . Diagnostic features of atopic dermatitis. Acta Derm Venerol (Stockh) 1980; 92 (Suppl): 44–47.

    Google Scholar 

  30. Germer S, Holland MJ, Higuchi R . High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res 2000; 10: 258–266.

    Article  CAS  Google Scholar 

  31. Terwillinger JD, Ott J . Handbook of Human Genetic Linkage. Johns Hopkins University Press, Baltimore, MD, 1994.

    Google Scholar 

  32. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA . Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425–434.

    Article  Google Scholar 

Download references

Acknowledgements

This research was supported by a Grant-in-Aid for research (nos. 11670813 and 13357008) from the Ministry of Education, Science, and Culture of Japan. We thank Dr James R McMillan for the proofreading of this manuscript.

Author information

Authors and Affiliations

  1. Department of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    T Shimizu, A Honda, Y Zhao, R Abe, H Watanabe & H Shimizu

  2. First Department of Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan

    N Hizawa & M Nishimura

  3. Genetic Laboratory, Sapporo, Japan

    J Nishihira

Authors
  1. T Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Hizawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Honda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Nishihira
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M Nishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T Shimizu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimizu, T., Hizawa, N., Honda, A. et al. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata. Genes Immun 6, 285–289 (2005). https://doi.org/10.1038/sj.gene.6364191

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6364191

Keywords

This article is cited by

Search

Advanced search

Quick links